Diabetes Professional Resources Online  /  American Diabetes Association
Home About Us Donate Now Join ADA
DiabetesPro Home
Meetings and Continuing Education Opportunities
Scientific Sessions Webcasts
Resources for Professionals
Clinical Practice
Recommendations
Professional Membership
Journals
Books for Professionals
Research Grant Applications and Administration
About Diabetes Research
Recognition Programs
Professional Section
Interest Groups
Professional Section
Quarterly
Point of Care
Thomson Reuters - Prous Science
 
The Cardiometabolic Risk Initiative

Facilitating Behavior Change: Key Strategies For Empowering Patients

Therapeutic lifestyle change is an essential component of treating patients with cardiometabolic risk. All members of the interdisciplinary health care team should have the knowledge and training to assess, facilitate, and empower patients to make healthy lifestyle changes.

This new activity from the American Diabetes Association will enhance the knowledge and skills of the health care professional by providing them with key strategies and case examples to assist them in obtaining optimum patient goals. Get free CE credit now.


What is Cardiometabolic Risk?

Cardiometabolic risk (CMR) is a construct that comprises a cluster of risk factors that are good indicators of a patient's overall risk for type 2 diabetes and cardiovascular disease (CVD). CMR focuses clinical attention on the value of systematic evaluation, education, lifestyle behavior changes, disease prevention, and treatment. Assessing cardiometabolic risk gives clinicians a more comprehensive picture of a patients' health and potential risk for future disease and complications.

Cardiometabolic risk factors include:

Overweight/Obesity

Inflammation & Hypercoagulation
High Blood Glucose Physical Inactivity
Hypertension Smoking
Abnormal Lipid Metabolism Age, Race and Ethnicity, Gender, & Family History

Factors Contributing to Cardiometabolic RiskEach of these risk factors pose a danger to good health, and the more your patients have, the greater their risk of type 2 diabetes and CVD.

Through a variety of educational and public awareness activities, the American Diabetes Association is working to educate patients about their cardiometabolic risk factors, helping them learn more about their risk for type 2 diabetes and heart disease so they can take action to lower their risk. First things first: We're encouraging patients to talk to their doctor, nurse practitioner, or physicians assistant about their risk.

Resources

Related Research

Learn more about cardiometabolic risk and preventing type 2 diabetes and cardiovascular disease:

--------------------------------------------------------------------------------

Cardiometabolic Risk Initiative is made possible by support from:

Eli Lilly & Company Merck & Merck/Schering-Plough Pharmaceuticals
Novartis Pfizer Inc.
sanofi-aventis Takeda Pharmaceuticals North America